Skip to main content
Fig. 3 | Journal of Translational Medicine

Fig. 3

From: Tumor angiogenesis at baseline identified by 18F-Alfatide II PET/CT may predict survival among patients with locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy

Fig. 3

ROC curve analysis of the predictive value of SUVs on baseline 18F-Alfatide II PET/CT imaging, applying OS as the dichotomous characteristic, revealing significant AUC values of 0.942 (P < 0.001) for SUVP (cutoff value, 4.64) and 0.895 (P = 0.001) for TBRP (cutoff value, 4.92)

Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us